Obtain Global Perspectives

As an attendee of IBC's Drug Discovery & Development JAPAN, you will have the opportunity to obtain global perspectives on scientific advances and R&D strategies to accelerate drug development. With over 40 international speakers and panelists from industry, academia and government, the conference program offers scientific, regulatory, clinical and commercial strategies for conducting drug development in the U.S. and Europe as part of a global R&D effort. The featured presentation this year from the FDA is one you can't afford to miss! Learn first hand from the Director, Division of Systems Toxicology, NCTR, U.S. FDA about their strategy for predictive toxicology and the FDA's perspective on integrating "omics" data in drug development.

Benchmark Your R&D Efforts and Learn from the Best

After extensive industry research, the sessions of this conference have been developed to ensure you learn innovative ideas that you can apply to your own research projects in order to accelerate NCE's, biologics and other therapeutics from discovery to the clinic:

• Participate in two audience interactive panel discussions: Understanding and Predicting Drug Liabilities and Antibodies and the Next Wave: Building a Biologics Franchise
• See how other companies are adding value to their businesses through "Open Innovation" and internationalization
• Find new technologies and build your network of potential international partners and collaborators.

Register today to learn updates on technologies and strategies for NCE discovery, worldwide progress on antibody technologies, antibody therapeutics and protein science, as well as the latest trends on RNAi as a therapeutic modality.

Why Attend this Event as Opposed to Other Events in Japan?

This event is specifically designed to provide an intimate experience for those who want to learn from and network with other scientists and executives who are actively looking for scientific and business strategies to accelerate drug discovery and development for their companies. The event features multiple speakers from the US, Europe and Japan who will share scientific approaches, technologies and case studies of many drug discovery projects, so that you can take home new ideas and lessons they have learned to implement in your own research activities. The event also offers a very unique opportunity to meet and learn from companies all over the world and to share strategies and partnership approaches to develop a drug for the global market. The size of this event...250-300 people....is specifically designed to allow attendees multiple opportunities to interact and network with other attendees and speakers during and after the conference. As opposed to much larger conferences and trade shows with thousands of attendees, where it is very difficult to find other attendees with similar interests and goals, you can be sure that attendees of this event share your similar interest in implementing the latest scientific and business/partnering strategies to accelerate discovery and development of innovative therapeutics. Simultaneous translation is provided for all presentations.